Market Research Logo

Global Monoclonal Antibodies Market 2018-2022

Global Monoclonal Antibodies Market 2018-2022

About this market

Rise in the number of companies venturing into monoclonal antibodies space to drive market growth. To gain profits, the companies are investing huge amounts in the development of monoclonal antibodies. At present, companies are expanding their businesses to increase the development and sales of monoclonal antibodies. Technavio’s analysts have predicted that the monoclonal antibodies market will register a CAGR of about 15% by 2022.

Market Overview

Introduction of low cost biosimilar monoclonal antibodies

The introduction of biosimilars aimed at curbing the increasing year-over-year cost of healthcare and handling the economic pressure from the patient pool and governments to reduce healthcare expenses, could be instrumental in reducing the cost of medication and increasing patient access to treatment.

High cost of monoclonal antibodies

Monoclonal antibodies cost high, both at end-user stage as well as the development stage, primarily owing to the use of highly advanced and expensive facilities.

For the detailed list of factors that will drive and challenge the growth of the monoclonal antibodies market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Johnson & Johnson and Merck the competitive environment is quite intense. Factors such as the rise in the number of companies venturing into monoclonal antibodies space and the introduction of low cost biosimilar monoclonal antibodies, will provide considerable growth opportunities to monoclonal antibodies manufactures. AbbVie, Amgen, Johnson & Johnson, and Merck are some of the major companies covered in this report.


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Monoclonal antibodies in the pipeline
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global monoclonal antibodies market - Market size and forecast 2017-2022 ($ bn)
      • Table Global monoclonal antibodies market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by application
    • Segmentation by application
      • Table Global monoclonal antibodies market by application - Market share 2017-2022 (%)
    • Comparison by application
      • Table Comparison by application
      • Table List of monoclonal antibodies approved by FDA/European Medicines Agency post 2015
    • Oncology - Market size and forecast 2017-2022
      • Table Oncology - Market size and forecast 2017-2022 ($ bn)
      • Table Oncology - Year-over-year growth 2018-2022 (%)
      • Table Sales of monoclonal antibodies in oncology ($ mn)
    • Immunology - Market size and forecast 2017- 2022
      • Table Immunology - Market size and forecast 2017-2022 ($ bn)
      • Table Sales of monoclonal antibodies for immunology ($ mn)
      • Table Immunology - Year-over-year growth 2018-2022 (%)
    • Hematology - Market size and forecast 2017- 2022
      • Table Hematology - Market size and forecast 2017-2022 ($ bn)
      • Table Hematology - Year-over-year growth 2018-2022 (%)
    • Others - Market size and forecast 2017-2022
      • Table Others - Market size and forecast 2017-2022 ($ bn)
      • Table Sales of monoclonal antibodies in the others segment ($ mn)
      • Table Others - Year-over-year growth 2018-2022 (%)
    • Market opportunity by application
      • Table Market opportunity by application
  • Market segmentation by origin of monoclonal antibodies
    • Segmentation by origin of monoclonal antibodies
    • Murine antibodies
    • Human antibodies
    • Humanized antibodies
    • Chimeric antibodies
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global monoclonal antibodies market by geography - Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ bn)
      • Table Sales of OPDIVO in the US market and the rest of the world.
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ bn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ bn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Increasing cases of diseases like cancer and immunological disorders
    • Rise in the number of companies venturing into the monoclonal antibodies space
    • Growing pricing pressure in the monoclonal antibodies segment
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors Covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie: An overview
      • Table AbbVie - Business segments
      • Table AbbVie - Organizational developments
      • Table AbbVie - Geographic focus
      • Table AbbVie - Segment focus
      • Table AbbVie - Key offerings
    • Amgen
      • Table Amgen: An overview
      • Table Amgen - Business segments
      • Table Amgen - Organizational developments
      • Table Amgen - Geographic focus
      • Table Amgen - Segment focus
      • Table Amgen - Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson: An overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Organizational developments
      • Table Johnson & Johnson - Geographic focus
      • Table Johnson & Johnson - Segment focus
      • Table Johnson & Johnson - Key offerings
    • Merck
      • Table Merck: An overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook